Takeda

CAMBRIDGE, Mass., March 28, 2026 Anumana, an AI-driven cardiovascular health technology company, announced that the U.S. Food and Drug...

OSAKA, Japan and CAMBRIDGE, Mass., March 28, 2026 Takeda announced positive results from its Phase 3 LATITUDE clinical trials...

CAMBRIDGE, Massachusetts, January 22, 2026 — Takeda Pharmaceutical Company Limited announced the U.S. availability of GAMMAGARD LIQUID ERC, the...